Corvia Medical Secures $55 Million Funding to Advance Heart Failure Treatment Trials Corvia Medical, Inc. has successfully closed a $55 million funding round aimed at completing its RESPONDER-HF trial and FDA approval process for its Atrial Shunt device.

Corvia Medical Secures $55 Million Funding to Advance Heart Failure Treatment Trials #USA #Heart_Failure #Corvia_Medical #Atrial_Shunt #Tewksbury

Corvia Medical Secures $55 Million to Propel Heart Failure Device Approval Process Corvia Medical has successfully raised $55 million to conduct a crucial trial for their innovative Atrial Shunt, aiming for FDA approval.

Corvia Medical Secures $55 Million to Propel Heart Failure Device Approval Process #USA #Heart_Failure #Corvia_Medical #Atrial_Shunt #Tewksbury

Corvia Medical Earns CE Certification for Innovative Atrial Shunt System in Europe Corvia Medical has achieved CE certification for its Atrial Shunt System under new EU standards, improving treatment options for heart failure patients.

Corvia Medical Earns CE Certification for Innovative Atrial Shunt System in Europe #USA #EU_MDR #Corvia_Medical #Atrial_Shunt #Tewksbury,_Massachusetts